Projects per year
Search results
-
Active
Phase IB/II Study Combining All-Trans Retinoic Acid (ATRA) with Carfilzomib Based Therapy in Plasma Cell Myeloma Patients Refractory to Carfilzomib
Pingali, S. R. (PI), Ganguly, S. (Key Personnel), Guan, J. (Key Personnel), Mai, H. P. (Key Personnel), Mathur, S. (Key Personnel), Shah, S. (Key Personnel) & Yi, Q. (Key Personnel)
7/29/24 → …
Project: Clinical Trial
-
Exploring the role and potential of anti-viral drugs to sensitize cancer cells to chemotherapy
Yi, Q. (PI)
6/1/24 → 5/31/29
Project: Federal Funding Agencies
-
Validating Novel Biologic Mediators and Therapeutic Targets in t(4;14) Myeloma
Yi, Q. (PI)
4/1/24 → 4/1/27
Project: Non Profit
-
Combination Therapy Using ATRA and Carfilzomib to Treat Proteasome Inhibitor Refractory Multiple Myeloma
Yi, Q. (PI)
3/1/24 → 2/28/28
Project: State
-
Tumor-specific CD8+ Tc9 cells activate host CD4+ T cells to control antigen-lost tumors
Yi, Q. (PI)
1/1/24 → 12/31/28
Project: Federal Funding Agencies
-
Role of lipid metabolism in CD8+ T cell ferroptosis
Yi, Q. (PI)
9/19/23 → 8/31/28
Project: Federal Funding Agencies
-
Novel mechanism of induction of tumor pyroptosis by IL-9-secreting Tc9 cells
Yi, Q. (PI)
8/1/23 → 7/31/28
Project: Federal Funding Agencies
-
DEVELOPING NOVEL CAR-T CELL THERAPY FOR HEMATOLOGIC MALIGNANCIES
Yi, Q. (PI)
7/1/23 → 6/30/26
Project: Non Profit
-
Targeting DKK1 with a DNA vaccine to prevent development of multiple myeloma
Yi, Q. (PI)
6/26/23 → 4/25/26
Project: Federal Funding Agencies
-
Role of tumor microenvironment-derived cholesterol in CD8+ T-cell exhaustion
Yi, Q. (PI)
8/1/19 → 7/31/25
Project: Federal Funding Agencies
-
Not started
Sample and Data Collection for Hematologic disorders section, Houston Methodist Cancer Center
Pingali, S. R. (PI), Ganguly, S. (Key Personnel), Heyne, K. (Key Personnel), Hu, C.-C. A. (Key Personnel), Jin, M. M. (Key Personnel), Rice, L. (Key Personnel), Shah, S. (Key Personnel), Yang, J. (Key Personnel), Yi, Q. (Key Personnel) & Zieske, A. W. (Key Personnel)
Project: Clinical Trial
-
Finished
Role of ATRA in Overcoming Myeloma Resistance to Proteasome Inhibitors
Yi, Q. (PI) & Wang, Q. (Key Personnel)
8/31/21 → 2/29/24
Project: State
-
Potentiation of Multi-peptide Lung Cancer Vaccines with Immune Checkpoint Antagonist CA-170
You, M. (PI) & Yi, Q. (Key Personnel)
5/24/21 → 8/23/24
Project: Federal Funding Agencies
-
Targeting macrophages to sensitize myeloma to immune checkpoint blockade
Yi, Q. (PI)
3/1/19 → 2/28/23
Project: Federal Funding Agencies
-
Role of MIF in myeloma bone homing and drug response
Yi, Q. (PI)
1/1/19 → 12/31/22
Project: Federal Funding Agencies
-
-
A novel T-cell subset able to kill relapsed cancers
Yi, Q. (PI)
7/1/16 → 6/30/22
Project: Federal Funding Agencies